NCT01190072View on ClinicalTrials.gov

Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)

TerminatedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Coronary Artery Disease
Trial Locations (1)

Unknown

Research Site, Maribor

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY